Loading clinical trials...
Loading clinical trials...
Basal cell carcinoma (BCC) is a slow-growing, locally invasive malignant epidermal skin tumour. It is the most common malignant disease in Caucasians, representing approximately 80% of all cases of sk...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Maastricht University Medical Center
NCT07144384 · Skin Basal Cell Carcinoma, Skin Nodular Basal Cell Carcinoma, and more
NCT06608238 · Nodular Basal Cell Carcinoma
NCT02270645 · Nodular Basal Cell Carcinoma, Superficial Basal Cell Carcinoma
NCT01808950 · Nodular Basal Cell Carcinoma
NCT02018679 · Nodular Basal Cell Carcinoma
Maastricht University medical Centre
Maastricht, Limburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions